- Filed
- May 24, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 7, 2024 | 8.11M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 8.11M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 8.11M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 8.09M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 8.09M sh |
| Capex | Q3 2024 · Mar 31, 2024 | $62.29K |
| Capex | Q3 2024 · Mar 31, 2023 | $26.09K |
| Operating Cash Flow | Q3 2024 · Mar 31, 2024 | −$63.89K |
| Operating Cash Flow restated | Q3 2024 · Mar 31, 2023 | −$133.24K |
| Stockholders Equity | Q3 2024 · Mar 31, 2024 | $2.25M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $2.35M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $2.59M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $2.62M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $2.61M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $2.64M |
| Stockholders Equity | Q3 2024 · Sep 30, 2022 | $2.66M |
| Stockholders Equity | Q3 2024 · Jun 30, 2022 | $2.67M |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $790.51K |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $626.12K |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $997.31K |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $946K |
| Current Assets | Q3 2024 · Mar 31, 2024 | $2.29M |
| Current Assets | Q3 2024 · Jun 30, 2023 | $2.24M |
| Total Assets | Q3 2024 · Mar 31, 2024 | $3.25M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $3.56M |
| Eps Diluted | Q3 2024 · Mar 31, 2024 | −$0.01 |
| Eps Diluted | Q3 2024 · Mar 31, 2024 | −$0.05 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | $0.00 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q3 2024 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q3 2024 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $503.21K |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $1.53M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $446.71K |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $1.35M |
| Net Income | Q3 2024 · Mar 31, 2024 | −$102.79K |
| Net Income | Q3 2024 · Mar 31, 2024 | −$379.12K |
| Net Income | Q3 2024 · Dec 31, 2023 | −$242.47K |
| Net Income | Q3 2024 · Sep 30, 2023 | −$33.86K |
| Net Income | Q3 2024 · Mar 31, 2023 | −$29.47K |
| Net Income | Q3 2024 · Mar 31, 2023 | −$57.74K |
| Net Income | Q3 2024 · Dec 31, 2022 | −$20.08K |
| Net Income | Q3 2024 · Sep 30, 2022 | −$8.19K |
| Operating Income | Q3 2024 · Mar 31, 2024 | −$81.79K |
| Operating Income | Q3 2024 · Mar 31, 2024 | −$240.6K |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$51.23K |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$94.23K |
| Gross Profit | Q3 2024 · Mar 31, 2024 | $937.77K |
| Gross Profit | Q3 2024 · Mar 31, 2024 | $2.79M |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $861.27K |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $2.63M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2024 | $260.77K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2024 | $784.8K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $263.55K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $851.91K |
| Revenue | Q3 2024 · Mar 31, 2024 | $1.2M |
| Revenue | Q3 2024 · Mar 31, 2024 | $3.57M |
| Revenue | Q3 2024 · Mar 31, 2023 | $1.12M |
| Revenue | Q3 2024 · Mar 31, 2023 | $3.48M |